These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16787368)

  • 61. The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in caco-2 cell model: contributions of glucose transporters and efflux systems.
    Moradi SV; Varamini P; Toth I
    J Pharm Sci; 2014 Oct; 103(10):3217-24. PubMed ID: 25174499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemical and enzymatic stability as well as transport properties of a Leu-enkephalin analogue and ester prodrugs thereof.
    Fredholt K; Adrian C; Just L; Hoj Larsen D; Weng S; Moss B; Juel Friis G
    J Control Release; 2000 Feb; 63(3):261-73. PubMed ID: 10601722
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Application and limitation of inhibitors in drug-transporter interactions studies.
    Wang Q; Strab R; Kardos P; Ferguson C; Li J; Owen A; Hidalgo IJ
    Int J Pharm; 2008 May; 356(1-2):12-8. PubMed ID: 18272304
    [TBL] [Abstract][Full Text] [Related]  

  • 67. H/dipeptide absorption across the human intestinal epithelium is controlled indirectly via a functional Na/H exchanger.
    Thwaites DT; Kennedy DJ; Raldua D; Anderson CM; Mendoza ME; Bladen CL; Simmons NL
    Gastroenterology; 2002 May; 122(5):1322-33. PubMed ID: 11984519
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
    Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
    Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ABC transporters in lipid transport.
    Borst P; Zelcer N; van Helvoort A
    Biochim Biophys Acta; 2000 Jun; 1486(1):128-44. PubMed ID: 10856718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
    Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
    Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipid, sugar and liposaccharide based delivery systems.
    Wong A; Toth I
    Curr Med Chem; 2001 Jul; 8(9):1123-36. PubMed ID: 11472244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line.
    Nielsen CU; Amstrup J; Steffansen B; Frokjaer S; Brodin B
    Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G191-9. PubMed ID: 11408272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
    Bhardwaj RK; Herrera-Ruiz D; Sinko PJ; Gudmundsson OS; Knipp G
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.
    Uchiyama T; Kotani A; Tatsumi H; Kishida T; Okamoto A; Okada N; Murakami M; Fujita T; Fujiwara Y; Kiso Y; Muranishi S; Yamamoto A
    Pharm Res; 2000 Dec; 17(12):1461-7. PubMed ID: 11303954
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(-/-) mice in vivo.
    Collett A; Tanianis-Hughes J; Hallifax D; Warhurst G
    Pharm Res; 2004 May; 21(5):819-26. PubMed ID: 15180340
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
    Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
    Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancement of systemic delivery of met-enkephalin and leu-enkephalin eyedrops with permeation enhancers.
    Chiou GC; Shen ZF; Zheng YQ; Li BH
    Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):361-6. PubMed ID: 1513191
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of oral drug absorption-effect of lipid conjugation on the enzymatic stability and intestinal permeability of l-Glu-l-Trp-NH(2).
    Bergeon JA; Toth I
    Bioorg Med Chem; 2007 Nov; 15(22):7048-57. PubMed ID: 17845857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.
    Hunter J; Hirst BH; Simmons NL
    Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.